Results 181 to 190 of about 3,791 (213)

Feasibility of individual dosimetry using RT-PHITS for patients with SPECT/CT imaging after 177Lu-DOTATATE peptide receptor radionuclide therapy

Physical and Engineering Sciences in Medicine
K. Miwa, R. Kakino, Tatsuhiko Sato, Takuya Furuta, Noriaki Miyaji, Tensho Yamao, Kosuke Yamashita, Takashi Terauchi   +7 more
semanticscholar   +1 more source

The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts

European Journal of Nuclear Medicine and Molecular Imaging, 2020
Sara Lundsten, Diana Spiegelberg, Nakul Ravi Raval   +2 more
exaly  

177Lu-DOTATATE in older patients with metastatic neuroendocrine tumours: safety, efficacy and health-related quality of life

European Journal of Nuclear Medicine and Molecular Imaging, 2021
Luohai Chen, Shaunak Navalkissoor, Gopinath Gnanasegaran   +2 more
exaly  

Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study

European Journal of Nuclear Medicine and Molecular Imaging, 2022
Dominique Clement, Shaunak Navalkissoor, Rajaventhan Srirajaskanthan   +2 more
exaly  

Neuroendocrine peritoneal disease and [177Lu]DOTATATE peptide receptor radionuclide therapy: a therapeutic challenge with potential clinical complications

European Journal of Nuclear Medicine and Molecular Imaging
Nathan Poterszman, Philippe Baltzinger, Darejan Mamulashvili Bessac, Floriane Pham Van, Bernard Goichot, Luc Mertz, Pietro Addeo, C. Brigand, Alessio Imperiale   +8 more
semanticscholar   +1 more source

The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis

Journal of Cancer Research and Clinical Oncology, 2020
Qi Song, Liang Cai, Ying Xie
exaly  

Systemic effects of 177Lu-DOTATATE therapy to patients with metastatic neuroendocrine tumors: mechanistic insights and role of exosome

European Journal of Nuclear Medicine and Molecular Imaging
Swati, Preetam Basak, B. R. Mittal, J. Shukla, V. Chadha   +4 more
semanticscholar   +1 more source

131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy

Annals of Nuclear Medicine, 2020
Sanjay Talole, Sandip Basu, Talole Sanjay   +2 more
exaly  

Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE

Frontiers in Oncology, 2021
Charlotte Atkinson, Balaji Ganeshan, Raymond Endozo   +2 more
exaly  

Treatment of progressive metastatic pheochromocytomas and paragangliomas with 177Lu-DOTATATE PRRT

Nuklearmedizin - NuclearMedicine, 2021
M Plotkin, D Beltsevich, M Michel, A Roslyakova, C Graf, C Neumann, F Musharbash, P Rumyantsev   +7 more
openaire   +1 more source